“Using Immunosuppressive Therapies to Treat Inflammatory Bowel Diseases (IBD) in the Post‑Cancer Setting”, Can IBD Today, vol. 3, no. 1, pp. 13–20, Jun. 2025, doi: 10.58931/cibdt.2025.3139.